Lorri Ballard
Psychiatric/Mental Health · Arlington, TXNPI 1124717434
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 225 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,952, more than ten times the $22 reported in 2023. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 225 payments — averaging $22.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$916
- Johnson & Johnson$785
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$753
- Otsuka America Pharmaceutical, Inc.$669
- Alkermes, Inc.$402
- Lundbeck LLC$355
- plus $1K from 15 others
What the payments were for
- Food & beverage$5,123100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $916 |
| Johnson & Johnson | 28 | $785 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $753 |
| Otsuka America Pharmaceutical, Inc. | 25 | $669 |
| Alkermes, Inc. | 19 | $402 |
| Lundbeck LLC | 21 | $355 |
| Axsome Therapeutics, Inc. | 11 | $241 |
| E.r. Squibb & Sons, L.L.C. | 5 | $203 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Tris Pharma Inc | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| Almatica Pharma LLC | 4 | $75 |
| Indivior Inc. | 3 | $63 |
| Idorsia Pharmaceuticals US Inc | 3 | $59 |
| OWP Pharmaceuticals, Inc. | 2 | $39 |
| Orexo US, Inc. | 2 | $33 |
| Noven Therapeutics, LLC | 1 | $23 |
| Neos Therapeutics, LP | 1 | $21 |
| Corium, LLC | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$270
- CAPLYTA$245
- REXULTI$243
- QELBREE$125
- INVEGA TRINZA$124
- Dyanavel XR$122
- Quillivant$122
- Quillichew ER$122
- COBENFY$120
- VRAYLAR$107
How this compares
$5,123 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 30 | $11,628 |
| Aripiprazole | 42 | $4,425 |
| Trazodone Hcl | 191 | $2,142 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 43 | $1,563 |
| Buspirone Hcl | 130 | $1,400 |
| Bupropion XlBupropion Hcl | 87 | $1,383 |
| Atomoxetine Hcl | 16 | $1,323 |
| Gabapentin | 73 | $1,022 |
| Duloxetine Hcl | 70 | $1,009 |
| Olanzapine | 22 | $1,001 |
| Quetiapine Fumarate | 109 | $985 |
| Oxcarbazepine | 32 | $894 |
| Hydroxyzine Hcl | 36 | $830 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $823 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 73 | $808 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Suboxone | $63 | $11,62830 claims |
| Almatica Pharma LLCSertraline Hcl | $75 | $45183 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Arlington
- Fredrick OdongoArlington$39K
- Christiana OmamegbeArlington$14K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.